Analysts expect Alterity Therapeutics Ltd to report revenue of 1.58 M for 2027, against a range of 1.47 M to 1.69 M. The most recent reported year, 2026, came in at 1.23 M, a 39.3% miss against the 2.03 M consensus.
| Metric | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 1,720.00 | 10,610.00 | 182,310.00 | 292,100.00 | 1.23 M | - | - | ||
| High Estimate | 3.00 M | 3.42 M | 2.94 M | 6.30 M | 2.13 M | 1.69 M | 3.90 M | ||
| Low Estimate | 2.77 M | 2.84 M | 2.46 M | 5.34 M | 1.93 M | 1.47 M | 3.33 M | ||
| Consensus Estimate | 2.89 M | 3.13 M | 2.70 M | 5.82 M | 2.03 M | 1.58 M | 3.62 M |
Analysts expect Alterity Therapeutics Ltd to report earnings per share of -0.24 for 2027, against a range of -0.25 to -0.23. The most recent reported year, 2026, came in at -0.08, a 80.5% beat against the -0.41 consensus.
| Metric | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | -2.36 | -2.39 | -2.30 | -0.81 | -0.08 | - | - | ||
| High Estimate | -3.36 | -1.35 | -1.89 | -1.02 | -0.37 | -0.23 | -0.33 | ||
| Low Estimate | -4.04 | -1.55 | -2.21 | -1.18 | -0.45 | -0.25 | -0.37 | ||
| Consensus Estimate | -3.70 | -1.45 | -2.05 | -1.10 | -0.41 | -0.24 | -0.35 |
Pull Wall Street consensus for Alterity Therapeutics Ltd (high, low and consensus estimates alongside reported actuals) into your own models and apps with the Business Quant Estimates API. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/estimates?ticker=ATHE&mode=revenue&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/estimates"
params = {"ticker": "ATHE", "mode": "revenue", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/estimates?ticker=ATHE&mode=revenue&api_key=YOUR_API_KEY");
const data = await res.json();